Inozyme Pharma, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Inozyme Pharma, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Inozyme Pharma, Inc. Return On Equity for the quarter ending September 30, 2024 was -88.4 %, a 58.1% decline year-over-year.
  • Inozyme Pharma, Inc. annual Return On Equity for 2023 was -55.9 %, a 3.41% decline from 2022.
  • Inozyme Pharma, Inc. annual Return On Equity for 2022 was -54 %, a 24.6% decline from 2021.
  • Inozyme Pharma, Inc. annual Return On Equity for 2021 was -43.4 %, a 54.8% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -55.9 -1.84 -3.41% Jan 1, 2023 Dec 31, 2023
2022 -54 -10.7 -24.6% Jan 1, 2022 Dec 31, 2022
2021 -43.4 +52.6 +54.8% Jan 1, 2021 Dec 31, 2021
2020 -96 -174 -224% Jan 1, 2020 Dec 31, 2020
2019 77.6 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.